S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:EVER

EverQuote (EVER) Stock Price, News & Analysis

$18.39
+0.27 (+1.49%)
(As of 04/19/2024 ET)
Today's Range
$18.12
$18.96
50-Day Range
$14.75
$19.97
52-Week Range
$5.36
$20.74
Volume
286,186 shs
Average Volume
368,416 shs
Market Capitalization
$629.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.60

EverQuote MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
12.0% Upside
$20.60 Price Target
Short Interest
Healthy
3.45% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.24mentions of EverQuote in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$7.66 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.43) to ($0.21) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.07 out of 5 stars

Finance Sector

646th out of 845 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

38th out of 57 stocks

EVER stock logo

About EverQuote Stock (NASDAQ:EVER)

EverQuote, Inc. operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc., and changed its name to EverQuote, Inc. in November 2014. EverQuote, Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

EVER Stock Price History

EVER Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
EverQuote (NASDAQ:EVER) Reaches New 52-Week High at $20.74
EverQuote (NASDAQ:EVER) Trading Up 2.1%
Everquote CFO sells shares worth over $160k
EverQuote Inc CFO Joseph Sanborn Sells 8,051 Shares
Everquote CTO sells shares worth over $42,000
EverQuote Inc CEO Jayme Mendal Sells 5,750 Shares
EVER Apr 2024 22.500 put
EVER Mar 2024 20.000 put
See More Headlines
Receive EVER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EverQuote and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2024
Today
4/19/2024
Next Earnings (Confirmed)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Current Symbol
NASDAQ:EVER
Fax
N/A
Employees
381
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.60
High Stock Price Target
$25.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+12.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-51,290,000.00
Pretax Margin
-17.61%

Debt

Sales & Book Value

Annual Sales
$287.92 million
Book Value
$2.37 per share

Miscellaneous

Free Float
21,065,000
Market Cap
$631.20 million
Optionable
Optionable
Beta
0.90
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives


EVER Stock Analysis - Frequently Asked Questions

Should I buy or sell EverQuote stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for EverQuote in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EVER shares.
View EVER analyst ratings
or view top-rated stocks.

What is EverQuote's stock price target for 2024?

5 analysts have issued 1 year price objectives for EverQuote's stock. Their EVER share price targets range from $13.00 to $25.00. On average, they anticipate the company's share price to reach $20.60 in the next year. This suggests a possible upside of 12.0% from the stock's current price.
View analysts price targets for EVER
or view top-rated stocks among Wall Street analysts.

How have EVER shares performed in 2024?

EverQuote's stock was trading at $12.24 on January 1st, 2024. Since then, EVER shares have increased by 50.2% and is now trading at $18.39.
View the best growth stocks for 2024 here
.

When is EverQuote's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our EVER earnings forecast
.

How can I listen to EverQuote's earnings call?

EverQuote will be holding an earnings conference call on Monday, May 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were EverQuote's earnings last quarter?

EverQuote, Inc. (NASDAQ:EVER) released its earnings results on Monday, February, 26th. The company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.12. The business had revenue of $55.71 million for the quarter, compared to analyst estimates of $49.89 million. EverQuote had a negative trailing twelve-month return on equity of 34.38% and a negative net margin of 17.81%.

What guidance has EverQuote issued on next quarter's earnings?

EverQuote issued an update on its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $78.0 million-$82.0 million, compared to the consensus revenue estimate of $65.1 million.

What is Jayme Mendal's approval rating as EverQuote's CEO?

31 employees have rated EverQuote Chief Executive Officer Jayme Mendal on Glassdoor.com. Jayme Mendal has an approval rating of 80% among the company's employees. 42.0% of employees surveyed would recommend working at EverQuote to a friend.

When did EverQuote IPO?

EverQuote (EVER) raised $0 in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 0 shares at a price of $0.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and Canaccord Genuity, JMP Securities, Needham, Oppenheimer, Raymond James and William Blair were co-managers.

Who are EverQuote's major shareholders?

EverQuote's stock is owned by many different institutional and retail investors. Top institutional shareholders include Counterpoint Mutual Funds LLC (0.11%). Insiders that own company stock include Craig Lister, Darryl Auguste, David B Blundin, David Brainard, David W Mason, Elyse Neumeier, George R Neble, Jayme Mendal, John Brandon Wagner, John L Shields, Jon Ayotte, Joseph Sanborn, Nicholas Graham, Paul F Deninger, Tomas Revesz Jr and Ventures Lllp Link.
View institutional ownership trends
.

How do I buy shares of EverQuote?

Shares of EVER stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EVER) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners